Vanguard Russell 2000 U.S. Small-Cap UCITS ETF

(VRSA) Vanguard Russell 2000 U.S. Small-Cap UCITS ETF - (USD) Accumulating

About this fund

Fund objectives

  • In seeking to achieve its investment objective, the Fund aims to provide a return which, before the application of fees and expenses, is similar to the return of the Index.
  • The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the Russell 2000® Index (the “Index”).
  • The Index measures the performance of the small-cap segment of the US equity universe. The Index is a subset of the Russell 3000® Index which is designed to represent approximately 98% of the investable US equity market. It includes approximately 2,000 of the smallest securities based on a combination of their market cap and current index membership.
  • The Fund attempts to: 1. Track the performance of the Index by fully replicating the Index, so that the Fund invests in all, or substantially all, of the constituents of the Index, making the weight of such investments approximate to those of the Index, to the extent practicable. 2. Remain fully invested except in extraordinary market, political or similar conditions where the Fund may temporarily depart from this investment policy to avoid losses.

Fund facts

Share class inception
Jul 07 2026
Listing date
Jul 09 2026
Investment structure
Irish UCITS
Share class assets'
Total assets
Risk indicator
Strategy
Index
Asset class
Equity
Investment Method
Physical
Index ticker
RU2000N
Benchmark
Russell 2000 Index
Dividend Schedule
—
Tax status
Austria, Germany, Switzerland and United Kingdom
Domicile
Ireland
Legal Entity
Vanguard Funds PLC
Siefores Approved
No

The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

Vehicles authorized for Siefores are those that meet the criteria issued by the CAR (Risk Analysis Committee) and are reviewed by an independent expert.

Performance

Risk and Volatility

-

Sorry, this information is not available yet. It will display a year after inception date.

Portfolio data

Characteristics
FundamentalsFundBenchmarkAs at
Number of stocks 1,972 1,962 Sep 30 2026
Median market capital 3.5 B 3.5 B Oct 31 2026
15.9 x 16.0 x Oct 31 2026
2.0 x 2.0 x Oct 31 2026
7.1% 7.1% Oct 31 2026
8.9% 9.0% Oct 31 2026
Portfolio turnover rate — — —
Market allocation

As at Sep 30 2026

CountryRegionFundBenchmarkVariance +/-
United States of AmericaNorth America 97.44% 97.10% 0.34%
OtherOther 0.93% 2.56% -1.63%
CanadaNorth America 0.71% — —
United KingdomEurope 0.32% — —
NorwayEurope 0.18% — —
BrazilEmerging Markets 0.15% 0.15% 0.00%
PanamaEmerging Markets 0.06% 0.05% 0.01%
IsraelMiddle East 0.05% 0.04% 0.01%
SingaporePacific 0.05% 0.05% 0.00%
IrelandEurope 0.04% — —
GreeceEurope 0.02% — —
ItalyEurope 0.02% — —
AustraliaPacific 0.02% — —
South AfricaEmerging Markets 0.01% — —
ChinaEmerging Markets 0.00% — —
Top 10 Holdings

As at Sep 30 2026

Holding name% of market valueSectorRegionMarket valueShares
Twist Bioscience Corp 0.43075% Health Care US $61,063.84 316
Moog Inc 0.36866% Industrials US $52,261.39 137
JFrog Ltd 0.35664% Technology US $50,557.84 521
10X Genomics Inc 0.35631% Health Care US $50,511.24 559
UMB Financial Corp 0.32374% Financials US $45,893.53 353
BrightSpring Health Services Inc 0.32066% Health Care US $45,456.75 801
Glaukos Corp 0.31851% Health Care US $45,152.25 275
Viasat Inc 0.30632% Telecommunications US $43,424.46 617
Hut 8 Corp 0.29943% Technology US $42,447.30 493
Cytokinetics Inc 0.29895% Health Care US $42,380.13 643

Prices and distribution

Prices

NAV Price (USD)
$93.83
USD
Change
-$0.29-0.31%
As at Nov 13 2026
Market price (USD)
$93.57
Change
-$1.63-1.71%
As at Nov 13 2026
NAV 52-week high
$102.94
As at Nov 14 2026
Market price 52-week high
$102.67
As at Nov 14 2026
NAV 52-week low
$91.46
As at Nov 14 2026
Market price 52-week low
$92.12
As at Nov 14 2026
NAV 52-week difference
$11.48
Change
+11.15%
As at Nov 14 2026
Market price 52-week difference
$10.55
Change
+10.28%
As at Nov 14 2026
Outstanding shares
153,826
As at Oct 31 2026
Discount
-$0.27
Change
-0.29%
As at Nov 13 2026
Historical Prices

-

Inception date

Jul 07 2026

Listing date

Jul 09 2026

Date NAV (USD) Market price (USD)
Nov 13 2026 $93.8332 $93.5650
Nov 12 2026 $94.1279 $95.1900
Nov 11 2026 $95.7123 $95.7050
Nov 10 2026 $94.8770 $94.3350
Nov 09 2026 $95.5214 $95.0150
Nov 06 2026 $92.6032 $92.3200
Nov 05 2026 $91.7805 $93.4650
Nov 04 2026 $96.0484 $95.3300
Nov 03 2026 $94.5530 $94.9700
Nov 02 2026 $94.3124 $95.4450

Purchase information

Currencies and stock exchanges

Listed currencies: MXN, USD, EUR, GBP

Base currency:USD

Exchanges: Bolsa Mexicana De Valores, SIX Swiss Exchange, NYSE Euronext - Amsterdam, Borsa Italiana S.p.A., Deutsche Boerse, London Stock Exchange

Fund codes